

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.81207346 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.04077944 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.93471429 |
| 4 | layer formation in cerebral cortex (GO:0021819) | 4.85785992 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.81889414 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 4.74182459 |
| 7 | glutamate secretion (GO:0014047) | 4.50476934 |
| 8 | vocalization behavior (GO:0071625) | 4.46724502 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.45069206 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.44498554 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.38650917 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.34746093 |
| 13 | regulation of synapse structural plasticity (GO:0051823) | 4.22842381 |
| 14 | protein localization to synapse (GO:0035418) | 4.12929891 |
| 15 | exploration behavior (GO:0035640) | 4.03668409 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.99423302 |
| 17 | proline transport (GO:0015824) | 3.95913225 |
| 18 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.88654185 |
| 19 | dendrite morphogenesis (GO:0048813) | 3.84034914 |
| 20 | dendritic spine morphogenesis (GO:0060997) | 3.79039099 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.73128498 |
| 22 | cell migration in hindbrain (GO:0021535) | 3.72714824 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.71070034 |
| 24 | response to peptidoglycan (GO:0032494) | 3.68690717 |
| 25 | neurotransmitter secretion (GO:0007269) | 3.62198491 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.57590152 |
| 27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.56431745 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.53563251 |
| 29 | neuron recognition (GO:0008038) | 3.48782391 |
| 30 | clathrin coat assembly (GO:0048268) | 3.38864046 |
| 31 | gamma-aminobutyric acid transport (GO:0015812) | 3.38565055 |
| 32 | negative regulation of microtubule polymerization (GO:0031115) | 3.33390022 |
| 33 | protein localization to endosome (GO:0036010) | 3.31769647 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 3.30560360 |
| 35 | axonal fasciculation (GO:0007413) | 3.30313937 |
| 36 | sodium ion export (GO:0071436) | 3.23542933 |
| 37 | postsynaptic membrane organization (GO:0001941) | 3.22493723 |
| 38 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.21719969 |
| 39 | neuronal action potential propagation (GO:0019227) | 3.21710393 |
| 40 | cellular potassium ion homeostasis (GO:0030007) | 3.20552462 |
| 41 | activation of protein kinase A activity (GO:0034199) | 3.20168873 |
| 42 | neuromuscular process controlling balance (GO:0050885) | 3.19316910 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 3.18091634 |
| 44 | negative regulation of cell killing (GO:0031342) | 3.16352370 |
| 45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.16352370 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.10006624 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.10006624 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.10006624 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 3.10006624 |
| 50 | positive regulation by symbiont of host defense response (GO:0052509) | 3.10006624 |
| 51 | modulation by symbiont of host defense response (GO:0052031) | 3.10006624 |
| 52 | synaptic transmission, glutamatergic (GO:0035249) | 3.09616058 |
| 53 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.08915990 |
| 54 | synaptic vesicle endocytosis (GO:0048488) | 3.08450222 |
| 55 | glutamate receptor signaling pathway (GO:0007215) | 3.07287360 |
| 56 | glycine transport (GO:0015816) | 3.04969158 |
| 57 | establishment of mitochondrion localization (GO:0051654) | 3.03869300 |
| 58 | response to auditory stimulus (GO:0010996) | 3.02845687 |
| 59 | response to muramyl dipeptide (GO:0032495) | 3.02371119 |
| 60 | positive regulation of synapse maturation (GO:0090129) | 2.98653320 |
| 61 | barbed-end actin filament capping (GO:0051016) | 2.97635747 |
| 62 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.97311775 |
| 63 | positive regulation of membrane potential (GO:0045838) | 2.97276916 |
| 64 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.97251135 |
| 65 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.97203935 |
| 66 | organelle transport along microtubule (GO:0072384) | 2.96784399 |
| 67 | long-term memory (GO:0007616) | 2.96264690 |
| 68 | neurotransmitter transport (GO:0006836) | 2.94058699 |
| 69 | axon cargo transport (GO:0008088) | 2.93122474 |
| 70 | nerve growth factor signaling pathway (GO:0038180) | 2.92622148 |
| 71 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92239600 |
| 72 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.90131636 |
| 73 | neuron-neuron synaptic transmission (GO:0007270) | 2.89508569 |
| 74 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.89413085 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89362000 |
| 76 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.88450254 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 2.88273041 |
| 78 | cerebellar Purkinje cell layer development (GO:0021680) | 2.88041299 |
| 79 | regulation of neurotransmitter secretion (GO:0046928) | 2.87926885 |
| 80 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.87575022 |
| 81 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.87236191 |
| 82 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.86302733 |
| 83 | mitochondrion transport along microtubule (GO:0047497) | 2.86302733 |
| 84 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.85710295 |
| 85 | vesicle transport along microtubule (GO:0047496) | 2.85361130 |
| 86 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.84275354 |
| 87 | auditory behavior (GO:0031223) | 2.84264487 |
| 88 | regulation of synaptic plasticity (GO:0048167) | 2.82925080 |
| 89 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.82195650 |
| 90 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.81185954 |
| 91 | nucleobase catabolic process (GO:0046113) | 2.80799292 |
| 92 | transmission of nerve impulse (GO:0019226) | 2.80692214 |
| 93 | regulation of vesicle fusion (GO:0031338) | 2.79756426 |
| 94 | regulation of ARF protein signal transduction (GO:0032012) | 2.79472552 |
| 95 | mating behavior (GO:0007617) | 2.77669888 |
| 96 | axon extension (GO:0048675) | 2.76647066 |
| 97 | positive regulation of axon extension (GO:0045773) | 2.76041655 |
| 98 | activation of MAPKKK activity (GO:0000185) | 2.75983609 |
| 99 | regulation of postsynaptic membrane potential (GO:0060078) | 2.75342656 |
| 100 | cerebellar granule cell differentiation (GO:0021707) | 2.74993272 |
| 101 | synapse assembly (GO:0007416) | 2.73207133 |
| 102 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.72602094 |
| 103 | regulation of leukocyte degranulation (GO:0043300) | 2.71082407 |
| 104 | adenosine receptor signaling pathway (GO:0001973) | 2.70476380 |
| 105 | germinal center formation (GO:0002467) | 2.69921036 |
| 106 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.69872667 |
| 107 | regulation of dendritic spine development (GO:0060998) | 2.69215847 |
| 108 | positive regulation of dendritic spine development (GO:0060999) | 2.69202996 |
| 109 | regulation of early endosome to late endosome transport (GO:2000641) | 2.69181584 |
| 110 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.68699863 |
| 111 | regulation of regulated secretory pathway (GO:1903305) | 2.68494477 |
| 112 | cell communication by electrical coupling (GO:0010644) | 2.66391706 |
| 113 | negative regulation of axonogenesis (GO:0050771) | 2.65941266 |
| 114 | innervation (GO:0060384) | 2.65658791 |
| 115 | regulation of neurotransmitter levels (GO:0001505) | 2.65228512 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 2.62668658 |
| 117 | dopamine receptor signaling pathway (GO:0007212) | 2.62118755 |
| 118 | adult walking behavior (GO:0007628) | 2.61683534 |
| 119 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.61665656 |
| 120 | L-amino acid import (GO:0043092) | 2.61533591 |
| 121 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.60806553 |
| 122 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.59480020 |
| 123 | neuromuscular process (GO:0050905) | 2.59331847 |
| 124 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.58790860 |
| 125 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.58216538 |
| 126 | synapse organization (GO:0050808) | 2.58002763 |
| 127 | regulation of mast cell degranulation (GO:0043304) | 2.56703831 |
| 128 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.56632457 |
| 129 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.56416172 |
| 130 | detection of molecule of bacterial origin (GO:0032490) | 2.50659415 |
| 131 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49812121 |
| 132 | NIK/NF-kappaB signaling (GO:0038061) | 2.48936777 |
| 133 | mannose metabolic process (GO:0006013) | 2.48758596 |
| 134 | stress fiber assembly (GO:0043149) | 2.46073111 |
| 135 | amino acid import (GO:0043090) | 2.45262531 |
| 136 | detection of other organism (GO:0098543) | 2.44608737 |
| 137 | positive regulation of type 2 immune response (GO:0002830) | 2.42876373 |
| 138 | positive regulation of protein dephosphorylation (GO:0035307) | 2.38581892 |
| 139 | positive regulation of Rap GTPase activity (GO:0032854) | 2.38158821 |
| 140 | regulation of type 2 immune response (GO:0002828) | 2.36203817 |
| 141 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.35533353 |
| 142 | positive regulation of macrophage cytokine production (GO:0060907) | 2.34087452 |
| 143 | regulation of ARF GTPase activity (GO:0032312) | 2.33907195 |
| 144 | macrophage activation (GO:0042116) | 2.33895706 |
| 145 | response to nerve growth factor (GO:1990089) | 2.32617607 |
| 146 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.32617607 |
| 147 | regulation of macrophage cytokine production (GO:0010935) | 2.32097302 |
| 148 | signal complex assembly (GO:0007172) | 2.31952200 |
| 149 | modulation by symbiont of host cellular process (GO:0044068) | 2.29815892 |
| 150 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.29274017 |
| 151 | cell-cell junction maintenance (GO:0045217) | 2.28909051 |
| 152 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.28086213 |
| 153 | detection of bacterium (GO:0016045) | 2.27474831 |
| 154 | glycosphingolipid catabolic process (GO:0046479) | 2.26782104 |
| 155 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.25410608 |
| 156 | detection of external biotic stimulus (GO:0098581) | 2.25275904 |
| 157 | positive regulation of regulated secretory pathway (GO:1903307) | 2.24265286 |
| 158 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.24118982 |
| 159 | cellular extravasation (GO:0045123) | 2.23030843 |
| 160 | negative regulation of type 2 immune response (GO:0002829) | 2.19536851 |
| 161 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.18102666 |
| 162 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.15584442 |
| 163 | positive regulation of leukocyte degranulation (GO:0043302) | 2.15288024 |
| 164 | immunoglobulin mediated immune response (GO:0016064) | 2.13171992 |
| 165 | granulocyte activation (GO:0036230) | 2.12925457 |
| 166 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.11528891 |
| 167 | positive regulation of mast cell degranulation (GO:0043306) | 2.11528891 |
| 168 | response to acidic pH (GO:0010447) | 2.11448735 |
| 169 | phagosome maturation (GO:0090382) | 2.10633861 |
| 170 | leukocyte aggregation (GO:0070486) | 2.10110298 |
| 171 | myeloid dendritic cell differentiation (GO:0043011) | 2.09757265 |
| 172 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.08961149 |
| 173 | myeloid cell activation involved in immune response (GO:0002275) | 2.08043412 |
| 174 | response to manganese ion (GO:0010042) | 2.07541414 |
| 175 | response to laminar fluid shear stress (GO:0034616) | 2.06481304 |
| 176 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.05857067 |
| 177 | positive regulation of receptor recycling (GO:0001921) | 2.05321809 |
| 178 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.05151736 |
| 179 | response to host immune response (GO:0052572) | 2.05151736 |
| 180 | amino sugar catabolic process (GO:0046348) | 2.04631341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.76643001 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89585238 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.80537724 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79443660 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.78057827 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63661911 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63661911 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.54645989 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.49284828 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48463533 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46576970 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44529268 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43761203 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42339491 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41623886 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36270860 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.34406020 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.29899894 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29267304 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.27979298 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20679885 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19581862 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18002401 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13351414 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13033824 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09535287 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04738928 |
| 28 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.04693665 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03248398 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.02643336 |
| 31 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.02145531 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97800484 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.95844080 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94652038 |
| 35 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93857036 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89761767 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83640843 |
| 38 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81401611 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79250565 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77353231 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67785741 |
| 42 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67059772 |
| 43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.61931059 |
| 44 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60442132 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59300607 |
| 46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.59161056 |
| 47 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58964612 |
| 48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57732866 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54104822 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.53695977 |
| 51 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53668232 |
| 52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53269855 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.52656334 |
| 54 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.50770039 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48205430 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45555214 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42115861 |
| 58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42029578 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41492140 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41093367 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39791945 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38998731 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37980633 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37972732 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.37556516 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36715922 |
| 67 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.35583844 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35456432 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33847527 |
| 70 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.33810340 |
| 71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33199592 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31822415 |
| 73 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31161596 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30861616 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30737977 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30579827 |
| 77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29960375 |
| 78 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29705745 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.29225810 |
| 80 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28130794 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27323212 |
| 82 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26563402 |
| 83 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26257853 |
| 84 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25201257 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23756269 |
| 86 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23354929 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22494049 |
| 88 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21857126 |
| 89 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19631567 |
| 90 | * MAF_26560356_Chip-Seq_TH1_Human | 1.19473329 |
| 91 | P68_20966046_ChIP-Seq_HELA_Human | 1.18431862 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18064979 |
| 93 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16784997 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16111068 |
| 95 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.15015205 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14777130 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14564388 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14003459 |
| 99 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13911478 |
| 100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13907261 |
| 101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13559259 |
| 102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13454104 |
| 103 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12990369 |
| 104 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12238748 |
| 105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12196925 |
| 106 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11806755 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11230693 |
| 108 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.11164926 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10731088 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10099217 |
| 111 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09630946 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08289871 |
| 113 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.07103562 |
| 114 | AR_19668381_ChIP-Seq_PC3_Human | 1.06993589 |
| 115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06955652 |
| 116 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06205385 |
| 117 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05441181 |
| 118 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05215534 |
| 119 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03719936 |
| 120 | * MAF_26560356_Chip-Seq_TH2_Human | 1.03565691 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02230983 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01888262 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01840491 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01215386 |
| 125 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00624342 |
| 126 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.99970343 |
| 127 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99078068 |
| 128 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98285385 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97874379 |
| 130 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97707003 |
| 131 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97144542 |
| 132 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96878599 |
| 133 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96730401 |
| 134 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95950191 |
| 135 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95770416 |
| 136 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95618437 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95588353 |
| 138 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93856950 |
| 139 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93763371 |
| 140 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93674095 |
| 141 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93375309 |
| 142 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92292222 |
| 143 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.91404422 |
| 144 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91098097 |
| 145 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90991009 |
| 146 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.89470036 |
| 147 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89341218 |
| 148 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87577767 |
| 149 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87155300 |
| 150 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.86531891 |
| 151 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86426953 |
| 152 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86240149 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85466381 |
| 154 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84463612 |
| 155 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83154564 |
| 156 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82087509 |
| 157 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81648189 |
| 158 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81146818 |
| 159 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.81128470 |
| 160 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80667424 |
| 161 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79863849 |
| 162 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.79761242 |
| 163 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79544432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.20197446 |
| 2 | MP0004270_analgesia | 4.12092817 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.77445565 |
| 4 | MP0003880_abnormal_central_pattern | 3.69386357 |
| 5 | MP0004858_abnormal_nervous_system | 3.22290041 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.06231143 |
| 7 | MP0003436_decreased_susceptibility_to | 2.96456624 |
| 8 | MP0002064_seizures | 2.88937730 |
| 9 | MP0009745_abnormal_behavioral_response | 2.86513377 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.80501812 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.78230136 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.71020287 |
| 13 | MP0009046_muscle_twitch | 2.62091442 |
| 14 | MP0003329_amyloid_beta_deposits | 2.52462433 |
| 15 | MP0002733_abnormal_thermal_nociception | 2.50812848 |
| 16 | MP0009840_abnormal_foam_cell | 2.48705263 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.48579637 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.45189236 |
| 19 | MP0000778_abnormal_nervous_system | 2.44707573 |
| 20 | MP0006082_CNS_inflammation | 2.32341795 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.23939603 |
| 22 | MP0001970_abnormal_pain_threshold | 2.22654919 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.22390682 |
| 24 | MP0009278_abnormal_bone_marrow | 2.22020990 |
| 25 | MP0001486_abnormal_startle_reflex | 2.17924892 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 2.13874395 |
| 27 | MP0001440_abnormal_grooming_behavior | 2.13779105 |
| 28 | MP0002272_abnormal_nervous_system | 2.11968909 |
| 29 | MP0002736_abnormal_nociception_after | 2.09353972 |
| 30 | MP0003724_increased_susceptibility_to | 2.09077790 |
| 31 | MP0002419_abnormal_innate_immunity | 2.06216331 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.98650565 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.97694984 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.92757531 |
| 35 | MP0002184_abnormal_innervation | 1.86635647 |
| 36 | MP0000955_abnormal_spinal_cord | 1.83840343 |
| 37 | MP0004885_abnormal_endolymph | 1.81075526 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.80083030 |
| 39 | MP0005025_abnormal_response_to | 1.79322871 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.78410628 |
| 41 | MP0008569_lethality_at_weaning | 1.75770024 |
| 42 | MP0009785_altered_susceptibility_to | 1.74558613 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.73706421 |
| 44 | MP0005451_abnormal_body_composition | 1.72150988 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.71928428 |
| 46 | MP0002822_catalepsy | 1.70312195 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.65149870 |
| 48 | MP0000920_abnormal_myelination | 1.65122708 |
| 49 | MP0008260_abnormal_autophagy | 1.65080110 |
| 50 | MP0000343_altered_response_to | 1.62910554 |
| 51 | MP0003634_abnormal_glial_cell | 1.60588496 |
| 52 | MP0004947_skin_inflammation | 1.59499256 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.58674188 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.58467138 |
| 55 | MP0004924_abnormal_behavior | 1.58428081 |
| 56 | MP0005386_behavior/neurological_phenoty | 1.58428081 |
| 57 | MP0005387_immune_system_phenotype | 1.57962182 |
| 58 | MP0001790_abnormal_immune_system | 1.57962182 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.54410409 |
| 60 | MP0002882_abnormal_neuron_morphology | 1.53441582 |
| 61 | MP0005623_abnormal_meninges_morphology | 1.52067672 |
| 62 | MP0000604_amyloidosis | 1.49161919 |
| 63 | MP0000569_abnormal_digit_pigmentation | 1.48002051 |
| 64 | MP0003303_peritoneal_inflammation | 1.47349497 |
| 65 | MP0001835_abnormal_antigen_presentation | 1.45204095 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.43401191 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.43145894 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.42916475 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 1.42862839 |
| 70 | MP0005166_decreased_susceptibility_to | 1.42007164 |
| 71 | MP0003633_abnormal_nervous_system | 1.39670217 |
| 72 | MP0003690_abnormal_glial_cell | 1.37856623 |
| 73 | MP0003879_abnormal_hair_cell | 1.34225597 |
| 74 | MP0002723_abnormal_immune_serum | 1.29772469 |
| 75 | MP0002452_abnormal_antigen_presenting | 1.28089040 |
| 76 | MP0009764_decreased_sensitivity_to | 1.25188702 |
| 77 | MP0003631_nervous_system_phenotype | 1.22865789 |
| 78 | MP0002152_abnormal_brain_morphology | 1.21847596 |
| 79 | MP0005671_abnormal_response_to | 1.21272161 |
| 80 | MP0001849_ear_inflammation | 1.20973781 |
| 81 | MP0000685_abnormal_immune_system | 1.19742133 |
| 82 | MP0002420_abnormal_adaptive_immunity | 1.18360925 |
| 83 | MP0001905_abnormal_dopamine_level | 1.17942649 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 1.17588598 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.17588598 |
| 86 | MP0001819_abnormal_immune_cell | 1.17366283 |
| 87 | MP0001800_abnormal_humoral_immune | 1.11829371 |
| 88 | MP0004142_abnormal_muscle_tone | 1.10941772 |
| 89 | MP0003828_pulmonary_edema | 1.10778239 |
| 90 | MP0003448_altered_tumor_morphology | 1.10101846 |
| 91 | MP0000858_altered_metastatic_potential | 1.09984898 |
| 92 | MP0003075_altered_response_to | 1.08444799 |
| 93 | MP0003279_aneurysm | 1.08232943 |
| 94 | MP0005464_abnormal_platelet_physiology | 1.08035090 |
| 95 | MP0003632_abnormal_nervous_system | 1.06718027 |
| 96 | MP0004510_myositis | 1.04341398 |
| 97 | MP0001502_abnormal_circadian_rhythm | 1.03910427 |
| 98 | MP0005409_darkened_coat_color | 1.03373209 |
| 99 | MP0004742_abnormal_vestibular_system | 1.02386050 |
| 100 | MP0002229_neurodegeneration | 1.01117541 |
| 101 | MP0001984_abnormal_olfaction | 1.00544109 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.98474745 |
| 103 | MP0001845_abnormal_inflammatory_respons | 0.95214482 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 0.94958860 |
| 105 | MP0001853_heart_inflammation | 0.94611647 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.93712991 |
| 107 | MP0010386_abnormal_urinary_bladder | 0.92972346 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.90965846 |
| 109 | MP0005076_abnormal_cell_differentiation | 0.89737654 |
| 110 | MP0001958_emphysema | 0.89262748 |
| 111 | MP0005310_abnormal_salivary_gland | 0.89057305 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.88238193 |
| 113 | MP0002405_respiratory_system_inflammati | 0.87477148 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.87004572 |
| 115 | MP0008469_abnormal_protein_level | 0.85380221 |
| 116 | MP0003122_maternal_imprinting | 0.85284733 |
| 117 | MP0002090_abnormal_vision | 0.84399480 |
| 118 | MP0005390_skeleton_phenotype | 0.84227340 |
| 119 | MP0002069_abnormal_eating/drinking_beha | 0.82675184 |
| 120 | MP0003283_abnormal_digestive_organ | 0.80989011 |
| 121 | MP0000751_myopathy | 0.80347024 |
| 122 | MP0008874_decreased_physiological_sensi | 0.79465610 |
| 123 | MP0002752_abnormal_somatic_nervous | 0.78662625 |
| 124 | MP0003787_abnormal_imprinting | 0.77429032 |
| 125 | MP0001529_abnormal_vocalization | 0.75309979 |
| 126 | MP0000716_abnormal_immune_system | 0.75251806 |
| 127 | MP0001851_eye_inflammation | 0.74781491 |
| 128 | MP0001177_atelectasis | 0.74604366 |
| 129 | MP0003861_abnormal_nervous_system | 0.74272053 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.73287298 |
| 131 | MP0003123_paternal_imprinting | 0.72865746 |
| 132 | MP0003566_abnormal_cell_adhesion | 0.69053714 |
| 133 | MP0008004_abnormal_stomach_pH | 0.69017221 |
| 134 | MP0005165_increased_susceptibility_to | 0.68838364 |
| 135 | MP0005646_abnormal_pituitary_gland | 0.68288011 |
| 136 | MP0001963_abnormal_hearing_physiology | 0.67001215 |
| 137 | MP0005499_abnormal_olfactory_system | 0.66152226 |
| 138 | MP0005394_taste/olfaction_phenotype | 0.66152226 |
| 139 | MP0005167_abnormal_blood-brain_barrier | 0.65526488 |
| 140 | MP0000534_abnormal_ureter_morphology | 0.62682512 |
| 141 | MP0005535_abnormal_body_temperature | 0.59701555 |
| 142 | MP0000013_abnormal_adipose_tissue | 0.59400533 |
| 143 | MP0003091_abnormal_cell_migration | 0.58902527 |
| 144 | MP0002653_abnormal_ependyma_morphology | 0.58662959 |
| 145 | MP0000631_abnormal_neuroendocrine_gland | 0.58191287 |
| 146 | MP0001943_abnormal_respiration | 0.56844004 |
| 147 | MP0004085_abnormal_heartbeat | 0.56401647 |
| 148 | MP0002089_abnormal_postnatal_growth/wei | 0.55511933 |
| 149 | MP0000747_muscle_weakness | 0.55340430 |
| 150 | MP0004233_abnormal_muscle_weight | 0.55015979 |
| 151 | MP0005058_abnormal_lysosome_morphology | 0.54882302 |
| 152 | MP0004130_abnormal_muscle_cell | 0.54848193 |
| 153 | MP0002751_abnormal_autonomic_nervous | 0.52097815 |
| 154 | MP0010769_abnormal_survival | 0.51670372 |
| 155 | MP0004145_abnormal_muscle_electrophysio | 0.51235184 |
| 156 | MP0003183_abnormal_peptide_metabolism | 0.50727551 |
| 157 | MP0010770_preweaning_lethality | 0.48573451 |
| 158 | MP0002082_postnatal_lethality | 0.48573451 |
| 159 | MP0008872_abnormal_physiological_respon | 0.48312879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.89345535 |
| 2 | Supranuclear gaze palsy (HP:0000605) | 4.86289118 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.61044306 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.61044306 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.61044306 |
| 6 | Focal motor seizures (HP:0011153) | 4.41491954 |
| 7 | Visual hallucinations (HP:0002367) | 4.31449671 |
| 8 | Focal seizures (HP:0007359) | 4.21382065 |
| 9 | Mutism (HP:0002300) | 4.15493784 |
| 10 | Neurofibrillary tangles (HP:0002185) | 4.08480239 |
| 11 | Action tremor (HP:0002345) | 3.81883920 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 3.78288703 |
| 13 | Ankle clonus (HP:0011448) | 3.67435520 |
| 14 | Epileptic encephalopathy (HP:0200134) | 3.56205590 |
| 15 | Termporal pattern (HP:0011008) | 3.50566030 |
| 16 | Insidious onset (HP:0003587) | 3.50566030 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.39752216 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.37879229 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.35041177 |
| 20 | Abnormality of the corticospinal tract (HP:0002492) | 3.34403876 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.30469186 |
| 22 | Papilledema (HP:0001085) | 3.25213676 |
| 23 | Atonic seizures (HP:0010819) | 3.14160449 |
| 24 | Loss of speech (HP:0002371) | 3.11224510 |
| 25 | Limb dystonia (HP:0002451) | 3.03500312 |
| 26 | Megalencephaly (HP:0001355) | 2.99775963 |
| 27 | Axonal loss (HP:0003447) | 2.91288608 |
| 28 | Diplopia (HP:0000651) | 2.87350138 |
| 29 | Abnormality of binocular vision (HP:0011514) | 2.87350138 |
| 30 | Nuclear cataract (HP:0100018) | 2.84068622 |
| 31 | Absence seizures (HP:0002121) | 2.83859215 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 2.83112315 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.82687510 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.81684737 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.81659004 |
| 36 | Recurrent abscess formation (HP:0002722) | 2.81490393 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.81162807 |
| 38 | Apathy (HP:0000741) | 2.79687347 |
| 39 | Akinesia (HP:0002304) | 2.79491999 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.78022041 |
| 41 | Generalized tonic-clonic seizures (HP:0002069) | 2.77027967 |
| 42 | Urinary urgency (HP:0000012) | 2.76604335 |
| 43 | Spastic gait (HP:0002064) | 2.68852176 |
| 44 | Depression (HP:0000716) | 2.65937355 |
| 45 | Polyphagia (HP:0002591) | 2.64542530 |
| 46 | Genetic anticipation (HP:0003743) | 2.63916024 |
| 47 | Dialeptic seizures (HP:0011146) | 2.63403766 |
| 48 | Amyloidosis (HP:0011034) | 2.60018984 |
| 49 | Dysmetria (HP:0001310) | 2.57492263 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55936023 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55936023 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55936023 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.55671996 |
| 54 | Broad-based gait (HP:0002136) | 2.55191272 |
| 55 | Orchitis (HP:0100796) | 2.54149476 |
| 56 | Poor eye contact (HP:0000817) | 2.51736194 |
| 57 | Obstructive sleep apnea (HP:0002870) | 2.50996364 |
| 58 | Diminished motivation (HP:0000745) | 2.50944436 |
| 59 | Myositis (HP:0100614) | 2.48182906 |
| 60 | Torticollis (HP:0000473) | 2.47890085 |
| 61 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.47351359 |
| 62 | Inappropriate behavior (HP:0000719) | 2.46905255 |
| 63 | Febrile seizures (HP:0002373) | 2.45875483 |
| 64 | Drooling (HP:0002307) | 2.45240407 |
| 65 | Excessive salivation (HP:0003781) | 2.45240407 |
| 66 | Amblyopia (HP:0000646) | 2.44667090 |
| 67 | Postural instability (HP:0002172) | 2.43781865 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43257589 |
| 69 | Mucopolysacchariduria (HP:0008155) | 2.43257589 |
| 70 | Lower limb muscle weakness (HP:0007340) | 2.41205811 |
| 71 | Mediastinal lymphadenopathy (HP:0100721) | 2.40179946 |
| 72 | Agitation (HP:0000713) | 2.38300632 |
| 73 | Impaired social interactions (HP:0000735) | 2.37260080 |
| 74 | Abnormal social behavior (HP:0012433) | 2.37260080 |
| 75 | Hemiparesis (HP:0001269) | 2.35805683 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.35657983 |
| 77 | Pheochromocytoma (HP:0002666) | 2.33502674 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32424426 |
| 79 | Intention tremor (HP:0002080) | 2.32245030 |
| 80 | Progressive inability to walk (HP:0002505) | 2.29921825 |
| 81 | Dysdiadochokinesis (HP:0002075) | 2.29884138 |
| 82 | Hyperacusis (HP:0010780) | 2.27352117 |
| 83 | Truncal ataxia (HP:0002078) | 2.24867373 |
| 84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.24664773 |
| 85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.24664773 |
| 86 | Rapidly progressive (HP:0003678) | 2.24494872 |
| 87 | Dementia (HP:0000726) | 2.21182909 |
| 88 | Cellulitis (HP:0100658) | 2.20561597 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 2.19621772 |
| 90 | Optic neuritis (HP:0100653) | 2.19621772 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 2.17766311 |
| 92 | Stereotypic behavior (HP:0000733) | 2.17450216 |
| 93 | Anxiety (HP:0000739) | 2.17402899 |
| 94 | Increased cerebral lipofuscin (HP:0011813) | 2.15360508 |
| 95 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.14830681 |
| 96 | Lower limb amyotrophy (HP:0007210) | 2.14727101 |
| 97 | Focal dystonia (HP:0004373) | 2.14001399 |
| 98 | Disinhibition (HP:0000734) | 2.10422299 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 2.09784812 |
| 100 | Hyperparathyroidism (HP:0000843) | 2.09227767 |
| 101 | Insomnia (HP:0100785) | 2.08247170 |
| 102 | Cerebral aneurysm (HP:0004944) | 2.07785788 |
| 103 | Peripheral hypomyelination (HP:0007182) | 2.02796599 |
| 104 | Vertebral compression fractures (HP:0002953) | 2.02470036 |
| 105 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.02002088 |
| 106 | Abnormality of the lower motor neuron (HP:0002366) | 2.01261703 |
| 107 | Hypercortisolism (HP:0001578) | 1.97455593 |
| 108 | Slow saccadic eye movements (HP:0000514) | 1.97235788 |
| 109 | Craniofacial dystonia (HP:0012179) | 1.96922215 |
| 110 | Gingivitis (HP:0000230) | 1.96914707 |
| 111 | Obstructive lung disease (HP:0006536) | 1.96331254 |
| 112 | Chronic obstructive pulmonary disease (HP:0006510) | 1.96331254 |
| 113 | Purpura (HP:0000979) | 1.95792634 |
| 114 | Polygenic inheritance (HP:0010982) | 1.94152221 |
| 115 | Achilles tendon contracture (HP:0001771) | 1.93323649 |
| 116 | Onion bulb formation (HP:0003383) | 1.93307942 |
| 117 | Neuroendocrine neoplasm (HP:0100634) | 1.93121767 |
| 118 | Personality changes (HP:0000751) | 1.91736718 |
| 119 | Distal lower limb muscle weakness (HP:0009053) | 1.91702624 |
| 120 | Bradykinesia (HP:0002067) | 1.91155135 |
| 121 | Ulnar claw (HP:0001178) | 1.91030304 |
| 122 | Macroorchidism (HP:0000053) | 1.90866511 |
| 123 | Hammertoe (HP:0001765) | 1.90697966 |
| 124 | Increased IgE level (HP:0003212) | 1.90436304 |
| 125 | Hypoplasia of the brainstem (HP:0002365) | 1.89572713 |
| 126 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.89572713 |
| 127 | EEG with generalized epileptiform discharges (HP:0011198) | 1.88123803 |
| 128 | Hypsarrhythmia (HP:0002521) | 1.88060444 |
| 129 | Aqueductal stenosis (HP:0002410) | 1.87900970 |
| 130 | Abnormality of the periventricular white matter (HP:0002518) | 1.86133729 |
| 131 | Gaze-evoked nystagmus (HP:0000640) | 1.86020554 |
| 132 | Postural tremor (HP:0002174) | 1.85269415 |
| 133 | Epileptiform EEG discharges (HP:0011182) | 1.85178612 |
| 134 | Absent speech (HP:0001344) | 1.84858354 |
| 135 | Hemiplegia (HP:0002301) | 1.83746738 |
| 136 | Asymmetric septal hypertrophy (HP:0001670) | 1.82786972 |
| 137 | Upper limb amyotrophy (HP:0009129) | 1.81731697 |
| 138 | Distal upper limb amyotrophy (HP:0007149) | 1.81731697 |
| 139 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81231471 |
| 140 | Clonus (HP:0002169) | 1.81211140 |
| 141 | Stomatitis (HP:0010280) | 1.81059307 |
| 142 | Rigidity (HP:0002063) | 1.79664687 |
| 143 | Generalized myoclonic seizures (HP:0002123) | 1.79005030 |
| 144 | Fetal akinesia sequence (HP:0001989) | 1.78852426 |
| 145 | Spontaneous hematomas (HP:0007420) | 1.78406423 |
| 146 | Distal lower limb amyotrophy (HP:0008944) | 1.78042471 |
| 147 | Failure to thrive in infancy (HP:0001531) | 1.77939503 |
| 148 | J-shaped sella turcica (HP:0002680) | 1.77182754 |
| 149 | Bronchomalacia (HP:0002780) | 1.76980624 |
| 150 | Hyperventilation (HP:0002883) | 1.75939691 |
| 151 | Progressive neurologic deterioration (HP:0002344) | 1.75637105 |
| 152 | Hypoventilation (HP:0002791) | 1.75375034 |
| 153 | Pointed chin (HP:0000307) | 1.74978002 |
| 154 | Memory impairment (HP:0002354) | 1.72921496 |
| 155 | Pathologic fracture (HP:0002756) | 1.72673021 |
| 156 | Foot dorsiflexor weakness (HP:0009027) | 1.72493539 |
| 157 | Decreased motor nerve conduction velocity (HP:0003431) | 1.70297542 |
| 158 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.70055955 |
| 159 | Thin bony cortex (HP:0002753) | 1.69729154 |
| 160 | Urinary incontinence (HP:0000020) | 1.68750839 |
| 161 | Upper motor neuron abnormality (HP:0002127) | 1.68162696 |
| 162 | Annular pancreas (HP:0001734) | 1.67227085 |
| 163 | Abnormality of the Achilles tendon (HP:0005109) | 1.64313745 |
| 164 | Glomerulonephritis (HP:0000099) | 1.62487747 |
| 165 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.62019422 |
| 166 | Global brain atrophy (HP:0002283) | 1.60924182 |
| 167 | Increased serum ferritin (HP:0003281) | 1.60512534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.06826337 |
| 2 | MAP3K9 | 3.99174253 |
| 3 | NTRK3 | 2.98523645 |
| 4 | MINK1 | 2.58506701 |
| 5 | NTRK1 | 2.51582662 |
| 6 | PAK6 | 2.45305013 |
| 7 | ERN1 | 2.40589872 |
| 8 | KSR2 | 2.39507446 |
| 9 | IRAK3 | 2.21553254 |
| 10 | EPHA4 | 2.16599065 |
| 11 | NTRK2 | 2.14998062 |
| 12 | MAP3K11 | 2.10966694 |
| 13 | MAP3K4 | 2.10313884 |
| 14 | DAPK2 | 1.96750723 |
| 15 | CAMKK1 | 1.93623581 |
| 16 | LATS2 | 1.82543482 |
| 17 | TAOK2 | 1.80361854 |
| 18 | PHKG1 | 1.77529087 |
| 19 | PHKG2 | 1.77529087 |
| 20 | PRKD3 | 1.62871967 |
| 21 | MAP2K3 | 1.59008443 |
| 22 | LIMK1 | 1.56802802 |
| 23 | SIK1 | 1.55628064 |
| 24 | SIK2 | 1.51590227 |
| 25 | TYRO3 | 1.51383515 |
| 26 | MAP2K7 | 1.50642367 |
| 27 | CDK5 | 1.48993713 |
| 28 | GRK5 | 1.48228271 |
| 29 | MAP3K2 | 1.45166788 |
| 30 | TBK1 | 1.44303898 |
| 31 | NME2 | 1.42955255 |
| 32 | KSR1 | 1.39477588 |
| 33 | MAP3K3 | 1.34859714 |
| 34 | RIPK4 | 1.34238327 |
| 35 | BLK | 1.32834990 |
| 36 | UHMK1 | 1.32632081 |
| 37 | MAP2K4 | 1.30763889 |
| 38 | MAPK13 | 1.29263518 |
| 39 | MAP3K14 | 1.29069496 |
| 40 | CAMKK2 | 1.29061493 |
| 41 | CSK | 1.21990285 |
| 42 | PLK2 | 1.20313284 |
| 43 | MOS | 1.18517579 |
| 44 | RET | 1.16456240 |
| 45 | TAOK1 | 1.15820986 |
| 46 | MAP4K1 | 1.15532110 |
| 47 | TYK2 | 1.15359980 |
| 48 | IRAK4 | 1.14545377 |
| 49 | DYRK2 | 1.14066814 |
| 50 | PRPF4B | 1.12172013 |
| 51 | ARAF | 1.10954628 |
| 52 | CSNK1G2 | 1.09371321 |
| 53 | ICK | 1.08864878 |
| 54 | MAP3K12 | 1.08058210 |
| 55 | PIM2 | 1.07837056 |
| 56 | CDK14 | 1.05663975 |
| 57 | CAMK1G | 1.03830838 |
| 58 | PAK3 | 1.03435505 |
| 59 | SIK3 | 1.03209791 |
| 60 | ZAP70 | 0.99947209 |
| 61 | CDK15 | 0.98720260 |
| 62 | TNK2 | 0.98509814 |
| 63 | CDK18 | 0.97646873 |
| 64 | TRIB3 | 0.96035568 |
| 65 | ALK | 0.95200540 |
| 66 | SMG1 | 0.89714981 |
| 67 | CDK19 | 0.88810127 |
| 68 | MARK2 | 0.87287102 |
| 69 | SCYL2 | 0.86764477 |
| 70 | CDK11A | 0.85759265 |
| 71 | CASK | 0.85385707 |
| 72 | PRKCG | 0.85104232 |
| 73 | STK11 | 0.84490536 |
| 74 | FGR | 0.82068901 |
| 75 | PRKCH | 0.81899394 |
| 76 | GRK7 | 0.81827255 |
| 77 | DDR2 | 0.80546364 |
| 78 | IRAK2 | 0.80497121 |
| 79 | TTN | 0.79869862 |
| 80 | PKN1 | 0.79579802 |
| 81 | PNCK | 0.79564507 |
| 82 | RIPK1 | 0.78806948 |
| 83 | ABL2 | 0.78435895 |
| 84 | FES | 0.77946060 |
| 85 | DAPK1 | 0.77299077 |
| 86 | PRKD2 | 0.75967795 |
| 87 | STK38 | 0.74245219 |
| 88 | LMTK2 | 0.72787310 |
| 89 | WNK1 | 0.71806961 |
| 90 | CAMK2A | 0.71478527 |
| 91 | OXSR1 | 0.68893377 |
| 92 | ERBB3 | 0.68735515 |
| 93 | STK39 | 0.67644517 |
| 94 | PRKCZ | 0.67092516 |
| 95 | SGK3 | 0.66972683 |
| 96 | TESK2 | 0.66728431 |
| 97 | MAP3K6 | 0.66591004 |
| 98 | JAK2 | 0.66522141 |
| 99 | CSNK1G3 | 0.65417330 |
| 100 | DYRK1B | 0.65086295 |
| 101 | SGK494 | 0.64485997 |
| 102 | SGK223 | 0.64485997 |
| 103 | RPS6KA2 | 0.63864014 |
| 104 | FYN | 0.63509316 |
| 105 | BMX | 0.63374548 |
| 106 | TESK1 | 0.62485008 |
| 107 | CSNK1A1L | 0.62391130 |
| 108 | IKBKE | 0.62378583 |
| 109 | MAP3K13 | 0.61870256 |
| 110 | PKN2 | 0.61658127 |
| 111 | JAK1 | 0.61633691 |
| 112 | HIPK2 | 0.61382684 |
| 113 | RPS6KL1 | 0.61218095 |
| 114 | RPS6KC1 | 0.61218095 |
| 115 | MAPK4 | 0.61148085 |
| 116 | HCK | 0.60556523 |
| 117 | FGFR4 | 0.59701104 |
| 118 | CAMK2B | 0.59397922 |
| 119 | PDPK1 | 0.56668974 |
| 120 | PTK6 | 0.56587191 |
| 121 | JAK3 | 0.56335262 |
| 122 | TGFBR2 | 0.55969440 |
| 123 | MAP3K1 | 0.55895976 |
| 124 | ROCK2 | 0.54711165 |
| 125 | DYRK1A | 0.54411353 |
| 126 | PDGFRA | 0.54242991 |
| 127 | DAPK3 | 0.52854331 |
| 128 | DMPK | 0.51545746 |
| 129 | TNIK | 0.51394770 |
| 130 | PRKCE | 0.50065857 |
| 131 | SYK | 0.49475707 |
| 132 | PRKG2 | 0.49052556 |
| 133 | MAP2K1 | 0.48614674 |
| 134 | EPHB2 | 0.47420819 |
| 135 | CAMK2G | 0.47364958 |
| 136 | PTK2B | 0.46824436 |
| 137 | PDK1 | 0.46715707 |
| 138 | EPHB1 | 0.45933829 |
| 139 | MATK | 0.45922389 |
| 140 | CAMK1D | 0.45792687 |
| 141 | CAMK1 | 0.45469152 |
| 142 | CSF1R | 0.45300366 |
| 143 | PTK2 | 0.44852082 |
| 144 | SGK1 | 0.44490279 |
| 145 | CDC42BPA | 0.42978410 |
| 146 | RAF1 | 0.39968950 |
| 147 | MAPK12 | 0.38613221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.89815520 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.27169091 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.25875805 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.10400424 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.10112516 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09218741 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.07983937 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.04018042 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.00853472 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 1.95784549 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.90795853 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.86081256 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.84646337 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.84237144 |
| 15 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.82546298 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76913505 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76429057 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.65887105 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.64638483 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.63824331 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60415540 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.57729448 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.56903361 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.50680450 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.44878457 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44734173 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44531157 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40747762 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.40472917 |
| 30 | Glioma_Homo sapiens_hsa05214 | 1.37566087 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36098220 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35425483 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35153605 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.33943132 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.30466335 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29571265 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29402258 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27642670 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.26669125 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.25882882 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23845678 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23527391 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.22661842 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.22630461 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21174485 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.18875626 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17629788 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15642826 |
| 49 | Taste transduction_Homo sapiens_hsa04742 | 1.12178169 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09329622 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06420550 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05699415 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04828403 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.01189264 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98332546 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98080379 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.97968489 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97820602 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97367430 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96895573 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.96262755 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95493727 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93960552 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93442222 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91739504 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.89848435 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.89438958 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87795201 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.87772510 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87684002 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86938300 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86637080 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.83899444 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82761386 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82296324 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.81937069 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81553010 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80435319 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.80025103 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79830891 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.79811833 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79707733 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78733509 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.77559022 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76909177 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76616087 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76489718 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75851677 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.74047664 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73901720 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73785456 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73336496 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73218798 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72780230 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72337133 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72071825 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.71708712 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71130247 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70524925 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69125740 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68638744 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68321597 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.65831664 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.64759620 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64300866 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.64050596 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.63785223 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63686530 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63310300 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62768840 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61877011 |
| 112 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61221915 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.59171588 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58085500 |
| 115 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56608604 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56311967 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55444638 |
| 118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54876823 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53965726 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53650905 |
| 121 | Tuberculosis_Homo sapiens_hsa05152 | 0.52099234 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.51753836 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51131945 |
| 124 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49795269 |
| 125 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49160541 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48503082 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47819829 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46960167 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46780090 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45911400 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45891156 |
| 132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45801094 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45139326 |

